Insufficient scRNA-seq data for expression of CRYGD at single-cell level.
Insufficient scRNA-seq data for expression of CRYGD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 96% | 165.03 | 172 / 180 | 15% | 4.77 | 64 / 430 |
brain | 74% | 25.84 | 1962 / 2642 | 21% | 0.88 | 145 / 705 |
prostate | 36% | 11.05 | 89 / 245 | 3% | 0.10 | 15 / 502 |
stomach | 22% | 2.09 | 79 / 359 | 3% | 0.10 | 9 / 286 |
heart | 14% | 4.66 | 118 / 861 | 0% | 0 | 0 / 0 |
pancreas | 1% | 0.07 | 4 / 328 | 12% | 1.59 | 22 / 178 |
bladder | 10% | 0.67 | 2 / 21 | 1% | 0.03 | 3 / 504 |
esophagus | 5% | 0.50 | 73 / 1445 | 4% | 0.86 | 7 / 183 |
peripheral blood | 8% | 0.80 | 75 / 929 | 0% | 0 | 0 / 0 |
intestine | 4% | 0.27 | 36 / 966 | 1% | 0.16 | 7 / 527 |
uterus | 4% | 0.28 | 6 / 170 | 1% | 0.11 | 6 / 459 |
eye | 0% | 0 | 0 / 0 | 4% | 0.16 | 3 / 80 |
skin | 1% | 0.08 | 13 / 1809 | 2% | 1.15 | 11 / 472 |
lung | 1% | 0.09 | 6 / 578 | 1% | 0.05 | 9 / 1155 |
adrenal gland | 0% | 0.04 | 1 / 258 | 1% | 0.19 | 3 / 230 |
kidney | 1% | 0.07 | 1 / 89 | 0% | 0.01 | 2 / 901 |
thymus | 0% | 0.01 | 1 / 653 | 1% | 0.03 | 5 / 605 |
breast | 1% | 0.05 | 3 / 459 | 0% | 0.00 | 2 / 1118 |
adipose | 0% | 0.03 | 5 / 1204 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.05 | 1 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
blood vessel | 0% | 0.01 | 3 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0007601 | Biological process | visual perception |
GO_0070306 | Biological process | lens fiber cell differentiation |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0005212 | Molecular function | structural constituent of eye lens |
Gene name | CRYGD |
Protein name | Gamma-crystallin D (Gamma-D-crystallin) (Gamma-crystallin 4) Crystallin, gamma D (Gamma-crystallin D) |
Synonyms | CRYG4 hCG_15938 |
Description | FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. |
Accessions | ENST00000644920.2 P07320 A0A140CTX7 ENST00000264376.5 |